Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05486182 | Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer(ESTROTIMP) | active not recruiting | Phase 4 | 153 | GE HealthcareINDUSTRY | 1 | Aug 14, 2025 | clinicaltrials |
| NCT05690828 | Evaluation of Cognitive Management for Chemobrain in Patients Treated for Breast Cancer.(e-ONCOGITE) | active not recruiting | N/A | 164 | Institut BergoniéOTHER | 1 | Aug 13, 2025 |
| clinicaltrials |
| NCT05057013 | A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours | active not recruiting | Phase 1 / Phase 2 | 81 | Cancer Research UKOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT03904173 | Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer(EMIT) | active not recruiting | — | 2,300 | Oslo University HospitalOTHER | 1 | Aug 8, 2025 | clinicaltrials |
| NCT04497285 | Real World Study Using Comprehensive Genomic Data on the Next Treatment Decision Making in Metastatic Breast Cancer(HOPE) | active not recruiting | — | 600 | SOLTI Breast Cancer Research GroupOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT06224244 | External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast Cancer Patients(ESIBIRE) | active not recruiting | Phase 2 | 180 | Regina Elena Cancer InstituteOTHER | 1 | Jul 25, 2025 | clinicaltrials |
| NCT05802225 | Clinical Study of the Efficacy and Safety of BCD-178 and Perjeta® as Neoadjuvant Therapy of HER2-Positive Breast Cancer(PREFER) | active not recruiting | Phase 3 | 398 | BiocadINDUSTRY | 1 | Jul 20, 2025 | clinicaltrials |
| NCT05257395 | A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer | active not recruiting | Phase 3 | 397 | Xuanzhu Biopharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 17, 2025 | clinicaltrials |
| NCT04915755 | Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease(ZEST) | active not recruiting | Phase 3 | 40 | GlaxoSmithKlineINDUSTRY | 27 | Jul 16, 2025 | clinicaltrials |
| NCT02436993 | Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab | active not recruiting | Phase 2 | 120 | University of California, IrvineOTHER | 1 | Jul 14, 2025 | clinicaltrials |
| NCT02455141 | Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer(TCTN) | active not recruiting | Phase 3 | 786 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT03725059 | Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756) | active not recruiting | Phase 3 | 1,240 | Merck Sharp & Dohme LLCINDUSTRY | 24 | Jul 11, 2025 | clinicaltrials |
| NCT02401685 | POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer(POSNOC) | active not recruiting | N/A | 1,900 | University Hospitals of Derby and Burton NHS Foundation TrustOTHER | 3 | Jul 10, 2025 | clinicaltrials |
| NCT04083963 | Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer | active not recruiting | Phase 2 | 13 | University of Illinois at ChicagoOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT03578484 | Breast Aesthetics by Three Dimensional Measures | active not recruiting | — | 32 | Sykehuset TelemarkOTHER_GOV | 1 | Jul 4, 2025 | clinicaltrials |
| NCT07048639 | Dosimetric Evaluation of Breathing Impact on PTV and Adjacent Organ At Risk in Breast Cancer Radiotherapy | active not recruiting | — | 22 | Superior UniversityOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT07044791 | Metabolic Parameters and Quality of Life in Women on Neo-/Adjuvant Therapy for Breast Cancer | active not recruiting | N/A | 120 | Federico II UniversityOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT07046195 | Optimal Combination of Adjuvant Radiotherapy and Immunotherapy for Breast Cancer | active not recruiting | — | 250 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT03831178 | Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting(DHA-WIN) | active not recruiting | Phase 2 | 76 | AHS Cancer Control AlbertaOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT05520515 | Water and Land-based Aerobic Training in Breast Cancer Survivors(WaterMama) | active not recruiting | N/A | 48 | Federal University of PelotasOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT06394661 | Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer | active not recruiting | Phase 2 | 109 | Henan Cancer HospitalOTHER_GOV | 1 | Jun 23, 2025 | clinicaltrials |
| NCT04541212 | Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia(CarChem) | active not recruiting | — | 169 | Montreal Heart InstituteOTHER | 1 | Jun 15, 2025 | clinicaltrials |
| NCT05104632 | Financial Toxicity in Breast Cancer Surgery | active not recruiting | — | 630 | McMaster UniversityOTHER | 1 | Jun 15, 2025 | clinicaltrials |
| NCT07018427 | Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer | active not recruiting | — | 70 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jun 12, 2025 | clinicaltrials |
| NCT02788981 | Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer | active not recruiting | Phase 2 | 29 | University of ChicagoOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT02804815 | Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours | active not recruiting | Phase 3 | 11,000 | University College, LondonOTHER | 2 | Jun 10, 2025 | clinicaltrials |
| NCT05346224 | A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer | active not recruiting | Phase 3 | 900 | Shanghai Henlius BiotechINDUSTRY | 4 | Jun 10, 2025 | clinicaltrials |
| NCT01953159 | Assessment of Paclitaxel-Induced Neuropathy | active not recruiting | — | 43 | University of ChicagoOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT03147430 | Early Detection of Breast Cancer in Women With Suspicious Mammograms | active not recruiting | — | 270 | Sentara Norfolk General HospitalOTHER | 1 | Jun 6, 2025 | clinicaltrials |
| NCT07008508 | Incidence of Venous Thromboembolism and Cardiovascular Events in Breast Cancer Patients Undergoing Cyclin-dependent Kinase 4/6 Inhibitors: The Breast Cancer Associated Vascular Events During Cyclin-dependent Kinase 4/6 Inhibitors Therapy (BRAVE-Cyclin) Study(BRAVE-Cyclin) | active not recruiting | — | 300 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jun 6, 2025 | clinicaltrials |
| NCT02546232 | Improved Breast Cancer Therapy (I-BCT-1) in the Neoadjuvant and Metastatic Setting | active not recruiting | Phase 2 | 196 | Oslo University HospitalOTHER | 1 | Jun 4, 2025 | clinicaltrials |
| NCT06856616 | Predicting Long-Term Clinical Outcomes in Chinese Breast Cancer Patients Receiving Neoadjuvant Chemotherapy | active not recruiting | — | 6,000 | The Third Affiliated Hospital of Harbin Medical UniversityOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT04166799 | Randomized Phase III Trial With Mepitel Film for the Prophylaxis of Radiation Dermatitis in Breast Cancer Patients | active not recruiting | N/A | 216 | Sunnybrook Health Sciences CentreOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT05594498 | A Study of StrataXRT in the Prevention of Radiation Dermatitis in Breast Cancer Patients | active not recruiting | N/A | 45 | Sunnybrook Health Sciences CentreOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT05510700 | Efficacy of Acupuncture Treatment for Breast Cancer-associated Insomnia | active not recruiting | N/A | 264 | Yin PingOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT02616432 | Tomosynthesis Mammographic Imaging Screening Trial(TMISTLead-in) | active not recruiting | N/A | 3,065 | Sunnybrook Health Sciences CentreOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT06865131 | Efficacy Study With StrataXRT for the Prophylaxis of Radiation Dermatitis in Adjuvant Breast Radiation Treatment in Large Breasted Women Using a Prone Technique | active not recruiting | N/A | 20 | Sunnybrook Health Sciences CentreOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT05251714 | CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer | active not recruiting | Phase 1 / Phase 2 | 44 | Treadwell Therapeutics, IncINDUSTRY | 1 | May 18, 2025 | clinicaltrials |
| NCT04585074 | Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery(MARRES) | active not recruiting | — | 2,000 | Severance HospitalOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT05409664 | Moving Forward Together 4(MFT4) | active not recruiting | N/A | 68 | University of South CarolinaOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT01247233 | Standard or Hypofractionated Radiotherapy Versus Accelerated Partial Breast Irradiation (APBI) for Breast Cancer(SHARE) | active not recruiting | N/A | 1,006 | UNICANCEROTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT05463601 | Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast Cancer | active not recruiting | Phase 2 | 132 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT03562637 | Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC | active not recruiting | Phase 3 | 575 | OBI Pharma, IncINDUSTRY | 13 | May 9, 2025 | clinicaltrials |
| NCT05179824 | Tempus Priority Study: A Pan-tumor Observational Study | active not recruiting | — | 1,000 | Tempus AIINDUSTRY | 1 | May 6, 2025 | clinicaltrials |
| NCT06957379 | Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard Therapy | active not recruiting | Phase 2 | 78 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | May 4, 2025 | clinicaltrials |
| NCT06190600 | Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy(SPORTNATHy) | active not recruiting | N/A | 40 | The Greater Poland Cancer CentreOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT04081805 | LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2)(EPMLARF) | active not recruiting | N/A | 195 | Federal University of São PauloOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT03161353 | Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.(PHERGain) | active not recruiting | Phase 2 | 377 | MedSIROTHER | 7 | Apr 23, 2025 | clinicaltrials |
| NCT03077191 | Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy: a Single Institution Experience(Ipomammella) | active not recruiting | — | 410 | IRCCS San RaffaeleOTHER | 1 | Apr 22, 2025 | clinicaltrials |
| NCT04125277 | The SONImage Study(SONImage) | active not recruiting | N/A | 100 | The Netherlands Cancer InstituteOTHER | 1 | Apr 18, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Aug 14, 2025source: clinicaltrials